coin-img-ETHETH+0.82%coin-img-BTCBTC+1.20%coin-img-SOLSOL+0.21%coin-img-XRPXRP+2.26%coin-img-UBOXUBOX+1,616.66%coin-img-USDCUSDC+0.02%coin-img-HYPEHYPE+0.90%coin-img-BNBBNB+0.18%coin-img-ETHETH+0.82%coin-img-BTCBTC+1.20%coin-img-SOLSOL+0.21%coin-img-XRPXRP+2.26%coin-img-UBOXUBOX+1,616.66%coin-img-USDCUSDC+0.02%coin-img-HYPEHYPE+0.90%coin-img-BNBBNB+0.18%coin-img-ETHETH+0.82%coin-img-BTCBTC+1.20%coin-img-SOLSOL+0.21%coin-img-XRPXRP+2.26%coin-img-UBOXUBOX+1,616.66%coin-img-USDCUSDC+0.02%coin-img-HYPEHYPE+0.90%coin-img-BNBBNB+0.18%coin-img-ETHETH+0.82%coin-img-BTCBTC+1.20%coin-img-SOLSOL+0.21%coin-img-XRPXRP+2.26%coin-img-UBOXUBOX+1,616.66%coin-img-USDCUSDC+0.02%coin-img-HYPEHYPE+0.90%coin-img-BNBBNB+0.18%
user-avatar
PR Newswire UK

Eisai reports Leqembi sales of JPY 29.3 billion in Q2 2026

AI Market Summary
BioArctic's partner Eisai reported Q2 2026 Leqembi global sales of JPY 29.3bn, implying SEK 179m in royalties to BioArctic, up ~10% YoY. Adjusting for a one-time China stockpiling effect in Q2 2025, underlying royalty growth was ~43%, reinforcing Leqembi's commercialization traction and supporting BioArctic's near-term fundamentals.
Impact level
● Low
Affected assets
BIO/USDT-6.30%
AI Insight · BIO/USDTAI Insight
▲ Bullish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
BioArctic AB said its global partner Eisai reported Leqembi® sales of 29.3 billion yen in the second quarter of 2026. Based on those sales, BioArctic is set to receive SEK 179 million in royalties, up about 10% year on year when excluding a one-off stockpiling impact in China in Q2 2025. The company said the royalty income reflects the monetization of its core commercialization rights and supports its equity fundamentals.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.